Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
Study sponsor: LeonaBio
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-10-23Actual
Enrollment · participants423Actual
Source updated2025-04-01Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.